MedTrace Logo

Pressure Wave Guided Atrial Fibrillation Cryoablation

NCT05603091 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-01-31

No results posted yet for this study

Summary

Prospective multicenter observational study evaluating the performance of pressure wave-guided atrial fibrillation cryoablation used in accordance with clinical practice guidelines.

Conditions

Interventions

PROCEDURE

cryoablation of pulmonary veins

Procedures are guided by pressure waveforms analysis, which are obtained by connecting the internal lumen of the catheter through the lateral port of the hemostatic valve attached to the catheter, to a pressure transducer connected in turn to a heparinized saline serum bag and to the cryoablation console.

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Hospital Universitario 12 de Octubre

    lead OTHER

Principal Investigators

  • Adolfo Fontenla, MD, PhD · Hospital Universitario 12 de Octubre, Madrid. Spain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-19
Primary Completion
2024-03-31
Completion
2024-06-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05603091 on ClinicalTrials.gov